长期COVID心肌炎:发生率,机制,临床影响和管理
Anjaneyulu Dunde1, Pankti Maniyar2, Nancy Vora3
1From the Department of Hospital Medicine, Baptist Medical Center South, Montgomery, AL.
Cardiology in review
|March 4, 2026
概括
长期的COVID可能会导致心肌炎,一种心脏炎症,比以前更频繁. 潜在的原因包括持续的病毒元素和免疫反应,需要仔细管理和运动限制.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 长期COVID (SARS-CoV-2感染的急性后续症状) 在感染后呈现持续的健康问题.
- 包括心肌炎在内的心脏并发症是已知的后果,即使是在轻度急性COVID-19之后.
- 了解长期COVID中的心肌炎对于患者的治疗结果至关重要.
研究的目的:
- 综合关于长期COVID中心肌炎的当前文献 (2022-2025年).
- 分析发病率,病理生理学,临床特征,诊断,管理和预后.
- 确定后COVID心肌炎的未来研究方向.
主要方法:
- 对2022年至2025年间发表的研究进行系统文献综述.
- 专注于详细介绍长期COVID患者心肌炎的研究.
- 综合与发病率,机制,临床表现,诊断,管理和预后相关的发现.
主要成果:
- 后COVID心肌炎是不常见的,但发生的频率比大流行前更高.
- 假设的机制包括持续的病毒存在,免疫媒介损伤,自身免疫和内皮功能障碍.
- 临床表现不同,从典型的心肌炎症状到疲劳和运动不耐受.
结论:
- 肌心炎是长期COVID的显著心脏并发症,具有多因素的起源.
- 管理是支持性的,包括运动限制,心力衰竭疗法和抗炎/免疫抑制剂.
- 需要进一步的研究,以充分阐明长期COVID心肌炎的机制和优化治疗策略.
相关概念视频
Myocarditis III: Medical Management
274
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
274
Myocarditis II: Clinical Features and Diagnostic Tests
392
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
392
Myocarditis IV: Nursing Management
328
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
328
Myocarditis I: Introduction
520
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
520
COPD: Pathogenesis and Clinical Features
2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
582
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
582
